242 related articles for article (PubMed ID: 27455849)
21. Improvements in the management of neutropenic sepsis: lessons learned from a district general hospital.
Wells T; Thomas C; Watt D; Fountain V; Tomlinson M; Hilman S
Clin Med (Lond); 2015 Dec; 15(6):526-30. PubMed ID: 26621939
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies.
Malik I; Hussain M; Yousuf H
J Infect; 2001 Feb; 42(2):120-5. PubMed ID: 11531318
[TBL] [Abstract][Full Text] [Related]
23. Randomized placebo-controlled trial of oral antibiotics in pediatric oncology patients at low-risk with fever and neutropenia.
Klaassen RJ; Allen U; Doyle JJ
J Pediatr Hematol Oncol; 2000; 22(5):405-11. PubMed ID: 11037850
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of bacteriologic cultures in choice of antibiotics in patients with chemotherapy-induced neutropenic sepsis.
Leong SS; Ang PT
Ann Acad Med Singap; 1997 Jul; 26(4):439-42. PubMed ID: 9395806
[TBL] [Abstract][Full Text] [Related]
25. Improving timeliness of antibiotic delivery for patients with fever and suspected neutropenia in a pediatric emergency department.
Volpe D; Harrison S; Damian F; Rachh P; Kahlon PS; Morrissey L; Mack J; Akenroye A; Stack AM
Pediatrics; 2012 Jul; 130(1):e201-10. PubMed ID: 22711718
[TBL] [Abstract][Full Text] [Related]
26. Association of time to antibiotics and clinical outcomes in adult hematologic malignancy patients with febrile neutropenia.
Butts AR; Bachmeier CC; Dressler EV; Liu M; Cowden A; Talbert J; Adams VR
J Oncol Pharm Pract; 2017 Jun; 23(4):278-283. PubMed ID: 28077045
[TBL] [Abstract][Full Text] [Related]
27. New strategies in the treatment of infectious complications in haematology and oncology: is there a role for out-patient antibiotic treatment of febrile neutropenia?
Karthaus M; Carratalà J; Jürgens H; Ganser A
Chemotherapy; 1998; 44(6):427-35. PubMed ID: 9755304
[TBL] [Abstract][Full Text] [Related]
28. Febrile neutropenia: median door-to-needle time - results of an initial audit.
Ali N; Baqir M; Hamid A; Khurshid M
Hematology; 2015 Jan; 20(1):26-30. PubMed ID: 24724830
[TBL] [Abstract][Full Text] [Related]
29. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials.
Vidal L; Paul M; Ben dor I; Soares-Weiser K; Leibovici L
J Antimicrob Chemother; 2004 Jul; 54(1):29-37. PubMed ID: 15201227
[TBL] [Abstract][Full Text] [Related]
30. Febrile neutropenic events in cancer patients: treatment for fever and neutropenia in young adult patients during intensive chemotherapy for solid tumours.
Nobbenhuis M; Cleton FJ
J Cancer Res Clin Oncol; 1992; 118(5):395-9. PubMed ID: 1583070
[TBL] [Abstract][Full Text] [Related]
31. Improving door-to-antibiotic time in severely septic emergency department patients.
Hitti EA; Lewin JJ; Lopez J; Hansen J; Pipkin M; Itani T; Gurny P
J Emerg Med; 2012 Apr; 42(4):462-9. PubMed ID: 21737222
[TBL] [Abstract][Full Text] [Related]
32. Bacterial lung sepsis in patients with febrile neutropenia.
Lanoix JP; Schmit JL; Douadi Y
Curr Opin Pulm Med; 2012 May; 18(3):175-80. PubMed ID: 22343426
[TBL] [Abstract][Full Text] [Related]
33. Assessing the Impact of ED Triage Directives on Febrile Oncology Patient Wait Times.
Leveille CF; Freeman SR; Kosalka PK; Hamel EM; Churchill IF; Giesbrecht J; Setrak RF; Law M
J Emerg Nurs; 2020 Mar; 46(2):254-262.e1. PubMed ID: 32164937
[TBL] [Abstract][Full Text] [Related]
34. Short-course intravenous antibiotics with oral quinolone prophylaxis in the treatment of neutropenic fever in autologous bone marrow or peripheral blood progenitor cell transplant recipients.
Mahendra P; Jacobson SK; Ager S; Bass G; Barker P; Johnson D; Baglin TP; Marcus RE
Acta Haematol; 1996; 96(2):64-7. PubMed ID: 8701702
[TBL] [Abstract][Full Text] [Related]
35. A Prospective Cohort Quality Improvement Study to Reduce the Time to Antibiotics for New Fever in Neutropenic Pediatric Oncology Inpatients.
Green AL; Yi J; Bezler N; Pikman Y; Tubman VN; Obeng EA; O'Neil T; Mersereau R; Morrissey L; Billett AL
Pediatr Blood Cancer; 2016 Jan; 63(1):112-7. PubMed ID: 26292080
[TBL] [Abstract][Full Text] [Related]
36. Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study.
Le Clech L; Talarmin JP; Couturier MA; Ianotto JC; Nicol C; Le Calloch R; Dos Santos S; Hutin P; Tandé D; Cogulet V; Berthou C; Guillerm G
Infect Dis (Lond); 2018 Jul; 50(7):539-549. PubMed ID: 29451055
[TBL] [Abstract][Full Text] [Related]
37. Implementation of a Nursing Based Order Set: Improved Antibiotic Administration Times for Pediatric ED Patients with Therapy-Induced Neutropenia and Fever.
Lukes T; Schjodt K; Struwe L
J Pediatr Nurs; 2019; 46():78-82. PubMed ID: 30856462
[TBL] [Abstract][Full Text] [Related]
38. Improving Antibiotic Timing in Febrile Neutropenia for Pediatric Oncology Patients with a Central Line.
Roseland J
J Pediatr Oncol Nurs; 2021; 38(3):185-189. PubMed ID: 33616449
[No Abstract] [Full Text] [Related]
39. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
[TBL] [Abstract][Full Text] [Related]
40. Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.
Lee DG; Kim SH; Kim SY; Kim CJ; Park WB; Song YG; Choi JH
Korean J Intern Med; 2011 Jun; 26(2):220-52. PubMed ID: 21716917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
